Sale!

Oxford American handbook of oncology 1st Edition by Lyman, Gary Herbert ISBN 0199708800 9780199708802

Original price was: $50.00.Current price is: $35.00.

Oxford American handbook of oncology 1st Edition Lyman Digital Instant Download

Author(s): Lyman, Gary Herbert
ISBN(s): 9780199708802, 0199708800
Edition: 1
File Details: PDF, 6.13 MB
Year: 2009
Language: english
SKU: EB-6639076 Category: Tags: ,

Oxford American handbook of oncology 1st Edition by Lyman, Gary Herbert – Ebook PDF Instant Download/Delivery:0199708800, 9780199708802
Full download Oxford American handbook of oncology 1st Edition after payment

Product details: 

ISBN 10: 0199708800 

ISBN 13: 9780199708802

Author: Lyman, Gary Herbert

Written by leading American practitioners, the Oxford American Handbooks of Medicine each offer a pocket-sized overview of an entire specialty, featuring instant access to guidance on the conditions that are most likely to be encountered. Precise and prescriptive, the handbooks offer up-to-date advice on examination, investigations, common procedures, and in-patient care. These books will be invaluable resources for residents and students, as well as a useful reference for practitioners. The essential reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Chapters focus on the immediate information needs in clinical decision making including treatment choices. Algorithms, best practice guidelines, highlight tables, and targeted lists of landmark references enhance concise text. The Handbook covers solid tumors and hematologic malignancies plus cancer biology, genetics, prevention and screening, cancer staging, complications, and supportive care. Why choose the Oxford American Handbook of Oncology? The design…. The Handbook uses a unique flexicover design that’s durable and practical. Compact, light, and fits in your pocket! Also has quick reference tabs, four-color presentation, and bookmark ribbons to help provide fast answers. The interior layout…. The Handbook is a quick reference in a small, innovative package. With one to two topics per page, it provides easy access and the emergency sections are in red to stand out. Icons throughout aid quick reference. The information…. The Handbook succinctly covers all the essential topics in a one or two-page spread format with colored headings that break up the text and provide a logical structure for readers of all levels. Common clinical questions are answered clearly and extensively. The history…. Oxford University Press is known around the world for excellence, tradition, and innovation. These handbooks are among the best selling in the world. The price…. You get an extremely useful tool at a great value!

Table of contents: 

Part 1 Background
1 Molecular cancer biology
Introduction to cancer
Molecular alterations in cancer
Cancer biology
2 Etiology and epidemiology
Genetic factors
Smoking
Alcohol
Diet
Infections
Gender
Sun exposure
Other radiation exposure
Chemical exposures
Further reading
Part 2 Cancer prevention and screening
3 Cancer prevention
Prevention strategies: introduction
Cancer: genetic, environmental, and infectious risks
Smoking-related cancers
The role of surgery in cancer prevention
Cancer chemoprevention
Clinical trials of cancer prevention
Cancer prevention: diet
Further reading
4 Cancer screening
Principles
Limitations
Screening tests
Further reading
5 Genetic screening
Introduction
General considerations
Specific syndromes
Developing issues
Further reading and resources
Part 3 Principles of management
6 Principles of cancer treatment
7 Surgical oncology
General principles
Tumor biology
Surgical techniques
Diagnosis and staging
Curative surgical resection
Palliative surgery
Surgery for metastatic disease
8 Principles of radiation oncology
Introduction
Principles of radiobiology
Principles of radiation physics
External beam radiotherapy (EBRT)
Specialized radiation therapy
9 Principles of chemotherapy
Rationale for combination therapy
Alkylating agents
Anti-tumor antibiotics
Antimetabolites
Cisplatin and derivatives
Topoisomerase inhibitors
Antimicrotubule agents
Drug resistance
Dose intensification
Chemoradiation
10 Hematopoietic stem cell transplantation
Introduction
Donor selection
Pretransplant evaluation
Conditioning regimens
Post-transplant complications
Long-term complications of HSCT
Donor lymphocyte infusion
11 Hormone therapy
Introduction
Types of endocrine therapy
Predictors of response
Resistance to hormone therapy
Controversies
12 Targeted therapies
Introduction
Small-molecule inhibitors
Antibodies
Conjugated agents
Proteasome inhibitors
Demethylation agents
Histone deacetylase (HDAC) inhibitors
13 Gene therapy and immunotherapy for cancer
Introduction
Manipulation of tumor suppressor genes and oncogenes
Introduction of chemotherapy sensitization and resistance genes
Immunotherapy for cancer
Gene delivery
14 Complementary and alternative medicine
Overview of complementary and alternative medicine (CAM)
Issues in cancer CAM
Major categories of CAM therapies
Further reading
15 Clinical trials
Introduction
History of clinical trials
The ethics of clinical research
Safety and efficacy considerations
Phases of clinical trials
Additional information
Part 4 Complications and supportive care
16 Anemia and fatigue
Introduction
Overview of treatment of anemia
Recommendations for the treatment of anemia
Safety considerations
Fatigue in patients with cancer
17 Febrile neutropenia
Introduction
Risk of febrile neutropenia
Complications of febrile neutropenia
Evaluation of the patient with febrile neutropenia
Empiric antibiotic therapy
Prophylaxis of febrile neutropenia
Key point summary
18 Pain management
Introduction
Assessment
Causes of cancer pain
Understanding the patient’s cancer pain
Management of cancer pain
Management of breakthrough pain
Other pain management interventions
Further reading
19 Venous thromboembolism
Risk of venous thromboembolism (VTE)
Consequences of VTE
Clinical presentation
Prevention and treatment of VTE
Clinical practice guidelines for prophylactic anticoagulation
Key point summary
Thrombosis of central venous catheters
20 Metabolic emergencies
Hypercalcemia
Hyponatremia
Hyperkalemia
Hyperglycemia and hypoglycemia
Acute renal failure in patients with malignant disease
Renal tubular dysfunction
Tumor lysis syndrome
21 Paraneoplastic syndromes
Introduction
Endocrine paraneoplastic syndromes
Neurological paraneoplastic syndromes
Hematological paraneoplastic syndromes
Dermatologic and skeletal paraneoplastic syndromes
Further reading
22 Superior vena cava syndrome and raised intracranial pressure
Superior vena cava (SVC) syndrome
Raised intracranial pressure (ICP)
23 Spinal cord compression
Spinal cord compression
24 Other obstructive complications
Bronchial obstruction and stridor
Intestinal obstruction
Obstructive jaundice
Urinary tract obstruction
25 Late effects of cancer treatment
Introduction
Endocrine and metabolic dysfunction
Fertility issues
Organ-specific problems
Secondary malignancies
Neuropsychological consequences
Further reading
26 End-of-life care
Introduction
Management of physical symptoms
Management of psychosocial symptoms
Care in the last days of life
Further reading
Part 5 Specific cancers
27 Thoracic cancers
Lung cancer
Non-small cell lung cancer (NSCLC)
Surgery for NSCLC
Chemotherapy for NSCLC
Radiation therapy for NSCLC
Small cell lung cancer (SCLC)
Chemotherapy for SCLC
Radiotherapy for SCLC
Mesothelioma
Thymic tumors
28 Breast cancer
Introduction
Epidemiology
Genetics of breast cancer
Pathology
Prognostic factors
Breast cancer screening
Presentation and staging
Management of noninvasive breast cancer
Management of early breast cancer
Management of locally advanced breast cancer
Follow-up of early-stage breast cancer patients
29 Gastrointestinal cancer I: esophagus, stomach, small intestine, carcinoid
Esophageal cancer
Gastric cancer
Small intestine and carcinoid tumors
30 Gastrointestinal cancer II: pancreas, biliary tract, hepatocellular
Pancreatic cancer
Cancers of the biliary tract
Hepatocellular carcinoma
31 Gastrointestinal cancer III: colorectal, anus
Colorectal cancer
Anal cancer
32 Endocrine cancers
Thyroid cancer
Surgery for thyroid cancer
Radio-iodine treatment for thyroid cancer
External beam radiotherapy for thyroid cancer
Chemotherapy for thyroid cancer
Surveillance, follow-up, and prognosis for thyroid cancer
Adrenal cancer
Neuroblastoma
33 Genitourinary cancers I: renal, bladder, ureter, penile carcinomas
Renal cancer
Cancer of the bladder and ureter
Penile cancer
Further reading
34 Genitourinary cancers II: prostate cancer
Prostate cancer
Management of prostate cancer
Treatment outcomes
Future directions
Further reading
35 Genitourinary cancers III: testicular cancer
Testicular cancer
Management of testicular cancer
Follow-up
Further reading
36 Gynecological cancer
Ovarian cancer
Cancer of the uterine corpus
Cancer of the cervix
Vulvar and vaginal cancer
37 Tumors of the central nervous system
Primary brain tumors
Primary CNS lymphoma
Brain metastases
Further reading
38 Head and neck cancers
Introduction
Etiology
Epidemiology
Screening and prevention
Pathology
Presentation
Investigations
Staging
Management
Prognosis and follow-up
Rehabilitation
Intraocular tumors
Further reading
39 Cutaneous malignancies
Malignant melanoma
Management of malignant melanoma
Intraocular melanoma
Non-melanoma skin cancer
Merkel cell carcinoma
Further reading
40 Soft tissue and bone sarcomas
General overview
Soft tissue sarcomas
Kaposi sarcoma
Other soft tissue sarcomas
Bone sarcomas
Other primary bone tumors
Surveillance
Suggested reading
41 Acute leukemia
Acute myeloid leukemia
Acute lymphoblastic leukemia (ALL)
42 Chronic leukemias and myelodysplastic syndromes
Chronic myeloid leukemia (CML)
Myelodysplastic syndromes (MDS)
Chronic lymphoid leukemias
43 Multiple myeloma
Introduction
Epidemiology and risk factors
Pathogenesis
Clinical features
Diagnosis
Staging and prognosis
Treatment
Suggested reading
44 Malignant lymphoma
Hodgkin lymphoma (HL)
Non-Hodgkin lymphomas (NHL)
Non-Hodgkin lymphomas and acquired immunodeficiency disorder
45 Cancer of unknown primary (CUP)
Clinical presentation
Initial workup
Metastases to lymph nodes and peritoneum
Metastases to other sites
Malignant pleural effusion
Etiology, pathology, and clinical presentation of CUP
Management of CUP

People also search for:

oxford handbook oncology pdf

oxford handbook oncology

oxford handbook of oncology

oncology handbook

oxford american handbook of cardiology

Tags:

Lyman,Gary Herbert,American